Eads & Heald Wealth Management
Source: SEC Form 13F · as of Mar 2026Eads & Heald Wealth Management holds 14 biotech & pharma companies tracked by BioSniper, totaling $18.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$18.2M
| Company | Shares | Value |
|---|---|---|
| CORCencora Inc. | 8,912 | $2.8M |
| AMGNAMGEN INC | 7,574 | $2.7M |
| JNJJOHNSON & JOHNSON | 9,754 | $2.4M |
| ABBVAbbVie Inc. | 9,268 | $2.0M |
| IDXXIDEXX LABORATORIES INC /DE | 2,924 | $1.6M |
| ABTABBOTT LABORATORIES | 14,123 | $1.5M |
| BMYBRISTOL MYERS SQUIBB CO | 21,429 | $1.3M |
| LLYELI LILLY & Co | 1,220 | $1.1M |
| GILDGILEAD SCIENCES, INC. | 6,128 | $854K |
| MRKMerck & Co., Inc. | 4,013 | $483K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,660 | $449K |
| ELVElevance Health Inc. | 1,480 | $433K |
| DGXQuest Diagnostics Incorporated | 1,549 | $304K |
| PFEPFIZER INC | 10,806 | $303K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.